SVF for Treating Pulmonary Fibrosis Post COVID-19
NCT06304623
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Fibrosis
Interventions
BIOLOGICAL:
Autologous adipose-derived SVF IV administration
Sponsor
Michael H Carstens
Collaborators
[object Object]
[object Object]
[object Object]